{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:53:20Z","timestamp":1792886000898,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T00:00:00Z","timestamp":1534896000000},"content-version":"vor","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.coi.2018.08.002","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T08:20:08Z","timestamp":1535962808000},"page":"209-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"C","title":["When designing vaccines, consider the starting material: the human B cell repertoire"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2880-3927","authenticated-orcid":false,"given":"Colin","family":"Havenar-Daughton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert K.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Schief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6484-6262","authenticated-orcid":false,"given":"Shane","family":"Crotty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2018.08.002_bib0005","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.coi.2018.08.002_bib0010","doi-asserted-by":"crossref","first-page":"a030262","DOI":"10.1101\/cshperspect.a030262","article-title":"What are the most powerful immunogen design vaccine strategies? Reverse vaccinology 2.0 shows great promise","volume":"9","author":"Burton","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.coi.2018.08.002_bib0015","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1084\/jem.20151960","article-title":"Reverse vaccinology 2.0: human immunology instructs vaccine antigen design","volume":"213","author":"Rappuoli","year":"2016","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2018.08.002_bib0020","doi-asserted-by":"crossref","first-page":"a029470","DOI":"10.1101\/cshperspect.a029470","article-title":"What are the most powerful immunogen design vaccine strategies? A structural biologist\u2019s perspective","volume":"9","author":"Kwong","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.coi.2018.08.002_bib0025","doi-asserted-by":"crossref","first-page":"e1005815","DOI":"10.1371\/journal.ppat.1005815","article-title":"Minimally mutated HIV-1 broadly neutralizing antibodies to guide reductionist vaccine design","volume":"12","author":"Jardine","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coi.2018.08.002_bib0030","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.chom.2012.09.008","article-title":"A blueprint for HIV vaccine discovery","volume":"12","author":"Burton","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2018.08.002_bib0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/imr.12512","article-title":"Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem","volume":"275","author":"Havenar-Daughton","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2018.08.002_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2017.11.023","article-title":"Precursor frequency and affinity determine B cell competitive fitness in germinal centers, tested with germline-targeting HIV vaccine immunogens","volume":"48","author":"Abbott","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2018.08.002_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ni.3680","article-title":"Defining B cell immunodominance to viruses","volume":"18","author":"Angeletti","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2018.08.002_bib0050","article-title":"Is it possible to develop a \u201cuniversal\u201d influenza virus vaccine? Outflanking antibody immunodominance on the road to universal influenza vaccination","author":"Angeletti","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.coi.2018.08.002_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.it.2018.04.008","article-title":"Understanding and manipulating viral immunity: antibody immunodominance enters center stage","author":"Angeletti","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coi.2018.08.002_bib0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/imr.12483","article-title":"Germline-targeting immunogens","volume":"275","author":"Stamatatos","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coi.2018.08.002_bib0065","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.immuni.2016.08.016","article-title":"HIV vaccine design to target germline precursors of glycan-dependent broadly neutralizing antibodies","volume":"45","author":"Steichen","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2018.08.002_bib0070","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1234150","article-title":"Rational HIV immunogen design to target specific germline B cell receptors","volume":"340","author":"Jardine","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.08.002_bib0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1126\/science.aac5894","article-title":"HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen","volume":"349","author":"Jardine","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.08.002_bib0080","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.cell.2015.06.003","article-title":"Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice","volume":"161","author":"Dosenovic","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.coi.2018.08.002_bib0085","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1126\/science.aad9195","article-title":"HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen","volume":"351","author":"Jardine","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.08.002_bib0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.08.005","article-title":"tailored immunogens direct affinity maturation toward HIV neutralizing antibodies","volume":"166","author":"Briney","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.coi.2018.08.002_bib0095","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1126\/science.aah3945","article-title":"Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice","volume":"353","author":"Sok","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.08.002_bib0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.07.029","article-title":"Induction of HIV neutralizing antibody lineages in mice with diverse precursor repertoires","volume":"166","author":"Tian","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.coi.2018.08.002_bib0105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat0381","article-title":"The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen","volume":"10","author":"Havenar-Daughton","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.coi.2018.08.002_bib0110","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.4049\/jimmunol.1102661","article-title":"The role of naive T cell precursor frequency and recruitment in dictating immune response magnitude","volume":"188","author":"Jenkins","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.08.002_bib0115","doi-asserted-by":"crossref","first-page":"D405","DOI":"10.1093\/nar\/gku938","article-title":"The immune epitope database (IEDB) 3.0","volume":"43","author":"Vita","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.coi.2018.08.002_bib0120","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1126\/science.aaa1342","article-title":"Humoral immunity. Apoptosis and antigen affinity limit effector cell differentiation of a single na\u00efve B cell","volume":"347","author":"Taylor","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.08.002_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2016.02.010","article-title":"Complex antigens drive permissive clonal selection in germinal centers","volume":"44","author":"Kuraoka","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2018.08.002_bib0130","article-title":"Anti-HIV-1 B cell responses are dependent on B cell precursor frequency and antigen-binding affinity","volume":"161","author":"Dosenovic","year":"2018","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.coi.2018.08.002_bib0135","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1084\/jem.20122574","article-title":"CXCR4 promotes B cell egress from Peyer\u2019s patches","volume":"210","author":"Schmidt","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2018.08.002_bib0140","doi-asserted-by":"crossref","first-page":"10871","DOI":"10.1073\/pnas.0802278105","article-title":"Monitoring cellular movement in vivo with photoconvertible fluorescence protein \u201cKaede\u201d transgenic mice","volume":"105","author":"Tomura","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.coi.2018.08.002_bib0145","doi-asserted-by":"crossref","first-page":"e1003586","DOI":"10.1371\/journal.pcbi.1003586","article-title":"Mathematical modeling reveals kinetics of lymphocyte recirculation in the whole organism","volume":"10","author":"Ganusov","year":"2014","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.coi.2018.08.002_bib0150","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.4049\/jimmunol.1700267","article-title":"Antigen acquisition enables newly arriving B cells to enter ongoing immunization-induced germinal centers","volume":"199","author":"Turner","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.08.002_bib0155","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1126\/science.aaa1300","article-title":"Host response. Inflammation-induced disruption of SCS macrophages impairs B cell responses to secondary infection","volume":"347","author":"Gaya","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.08.002_bib0160","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1126\/science.1144830","article-title":"Regulation of homeostatic chemokine expression and cell trafficking during immune responses","volume":"317","author":"Mueller","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.08.002_bib0165","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.immuni.2013.04.012","article-title":"Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies","volume":"39","author":"Zhou","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2018.08.002_bib0170","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nsmb.3291","article-title":"Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site","volume":"23","author":"Gristick","year":"2016","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coi.2018.08.002_bib0175","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.immuni.2016.10.027","article-title":"Identification of a CD4-binding-site antibody to HIV that evolved near-pan neutralization breadth","volume":"45","author":"Huang","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2018.08.002_bib0180","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.1187659","article-title":"Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1","volume":"329","author":"Wu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.08.002_bib0185","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1126\/science.1207227","article-title":"Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding","volume":"333","author":"Scheid","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.08.002_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2017.05.007","article-title":"Elicitation of robust tier 2 neutralizing antibody responses in nonhuman primates by hiv envelope trimer immunization using optimized approaches","volume":"46","author":"Pauthner","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2018.08.002_bib0195","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1084\/jem.20112272","article-title":"Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen","volume":"209","author":"Taylor","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2018.08.002_bib0200","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1126\/science.1201730","article-title":"Different B cell populations mediate early and late memory during an endogenous immune response","volume":"331","author":"Pape","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.08.002_bib0205","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1126\/science.149.3687.998","article-title":"Focal antibody production by transferred spleen cells in irradiated mice","volume":"149","author":"Playfair","year":"1965","journal-title":"Science"},{"key":"10.1016\/j.coi.2018.08.002_bib0210","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.immuni.2015.12.004","article-title":"A temporal switch in the germinal center determines differential output of memory b and plasma cells","volume":"44","author":"Weisel","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2018.08.002_bib0215","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.4049\/jimmunol.1002163","article-title":"Cutting edge: hierarchy of maturity of murine memory B cell subsets","volume":"185","author":"Tomayko","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.08.002_bib0220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/eji.1830040302","article-title":"Frequency of hapten-specific B cells in neonatal and adult murine spleens","volume":"4","author":"Press","year":"1974","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.coi.2018.08.002_bib0225","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.4049\/jimmunol.114.4.1354","article-title":"The frequency of phosphorylcholine-specific B cells in conventional and germfree BALB\/C mice","volume":"114","author":"Sigal","year":"1975","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.08.002_bib0230","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.4049\/jimmunol.119.3.1129","article-title":"The frequency of para-azophenylarsonate and dimethylaminonapthalene-sulfonyl-specific B cells in neonatal and adult BALB\/c mice","volume":"119","author":"Sigal","year":"1977","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2018.08.002_bib0235","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.immuni.2016.10.033","article-title":"HIV broadly neutralizing antibodies: taking good care of the 98","volume":"45","author":"Sok","year":"2016","journal-title":"Immunity"},{"issue":"Feburary (2)","key":"10.1016\/j.coi.2018.08.002_bib0240","article-title":"Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation","volume":"48","author":"Goodwin","year":"2018","journal-title":"Immunity"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791517302078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791517302078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:47:12Z","timestamp":1760604432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791517302078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":48,"alternative-id":["S0952791517302078"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2018.08.002","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When designing vaccines, consider the starting material: the human B cell repertoire","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2018.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}